Catalog Number ENC452812 |
Device Problems
Break (1069); Failure to Advance (2524)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 08/15/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).Information regarding patient identifier, date of birth, age, gender, weight, race, and ethnicity were not provided.Section e.1: the initial reporter phone:(b)(6).The initial reporter email address was not available / reported.Section h.3: the device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ in this section as the reason for non-evaluation.If the device returns, a device investigation will be performed.Lake region medical performed a review of the device history records relative to the manufacturing, inspection, and packaging of the lot 7632773.The history record indicates this product was final inspection tested at lake region medical and was determined to be acceptable.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Event Description
|
The healthcare professional reported that during an endovascular embolization procedure, the complaint stent, a 4.5mm x 28mm enterprise® vascular reconstruction device (enc452812 / 7632773) was impeded in the introducer sheath and could not be pushed into the microcatheter.The physician retracted the stent and switched to a new stent to complete the procedure using the original microcatheter.There was no report of any negative patient impact.On 01-sep-2023, additional information was received.The information indicated that information related to the target vessel was not obtainable.The stent markers were observed kinked / bent.Nothing was noted to be obstructing the introducer.A continuous flush was maintained through the microcatheter.The introducer was flushed until liquid was visible at the distal end of the slit in the clear tube.The tip of the introducer was firmly installed into the hub of the microcatheter and locked with the rotating hemostasis valve (rhv) during the device advancement.Based on the additional information received on 01-sep-2023, the markers were reported to be kinked / bent.The event has been deemed usfda reportable under 21 cfr 803 with a classification of ¿malfunction.¿.
|
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to report that the product was received in the product analysis lab on 14-sep-2023.The returned product is pending evaluation.A supplemental 3500a report will be submitted once the product investigation has been completed.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Manufacturer Narrative
|
Manufacturer¿s ref.No: (b)(4).The purpose of this mdr submission is to report the investigation finding of the returned device.The complaint device was returned for evaluation and analysis.The investigation finding is documented below.Investigation summary: a non-sterile 4.5mm x 28mm enterprise® vascular reconstruction device was received contained in the decontamination pouch.Visual inspection was performed.It was noted that the introducer was not returned.One (1) strut on the stent component was observed kinked.No damages were observed on the delivery wire.The stent component was inspected under the microscope.Under magnification, the struts of one marker were observed bent.Additionally, one strut was observed broken.No other damages were observed.Dimensional analysis was performed to analyze the diameter of the retraction bump and marker band distance.All measurements were found to be within specifications.Lake region medical performed a review of the device history records relative to the manufacturing, inspection, and packaging of the lot 7632773.The history record indicates this product was final inspection tested at lake region medical and was determined to be acceptable.As part of the cerenovus quality process, all devices are manufactured, inspected, and released to approved specifications.The issue reported regarding the stent being impeded in the introducer could not be evaluated due to the detached condition of the stent.This component must still be attached to the delivery wire and inside the introducer to be able to perform a functional test.However, the issue reported regarding the stent markers being kinked/bent was confirmed based on the damaged condition of the returned stent.The damage suggests that excessive force may have inadvertently been exerted on the enterprise system during the advancement attempts and is possible that the stent was not fully inside of the microcatheter which ultimately result in the marker band breakage.It is also suggested that clinical and procedural factors, including device manipulation and operator's technique, may have contributed to the reported failure.There is no indication that the issues reported in the complaint are a result of a defect inherently related to the enterprise device.The exact time of the stent detachment could not be determined; however, it is suggested that it may have occurred during the manipulation required during the device¿s withdrawal.It should be noted that product failure could be caused by multiple factors.The instructions for use (ifu) does contain the following recommendations: ¿ if resistance is met during manipulation, determine the cause of resistance before proceeding.¿ do not apply undue force if resistance is encountered at any point during stent manipulation.Withdraw the unit and advance a new one.¿ if resistance is felt while recapturing the stent, do not continue to recapture the device.Withdraw the infusion catheter slightly to unsheathe the stent (without exceeding the recapture limit), and then attempt to recapture the stent again.Based on the manufacturing documentation review, there is no indication that the event is related to the device manufacturing process.As part of the post market surveillance program, information from this complaint is trended for statistical signals and corrective / preventive action may be triggered at a later time.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.Updated sections: b.4, g.3, g.6.H.2, h.3, h.6, and h.10.The manufacturer will submit a supplemental report if new facts arise which materially alter information submitted in a previous mdr report.Additional information will be submitted within 30 days of receipt.
|
|
Search Alerts/Recalls
|
|